Metabolomics Workbench : NIH Data Repository

Analysis	Metabolite Name	Measured Value	Units	Sample	TREATMENT
Reversed phase NEGATIVE ION MODE	nicotinamide	0.4624	Peak area	Plasma	Angiotensin II
Reversed phase NEGATIVE ION MODE	nicotinamide	0.5664	Peak area	Plasma	Saline
Reversed phase NEGATIVE ION MODE	nicotinamide	0.6606	Peak area	Plasma	Angiotensin II
Reversed phase NEGATIVE ION MODE	nicotinamide	0.7079	Peak area	Plasma	Angiotensin II
Reversed phase NEGATIVE ION MODE	nicotinamide	0.7865	Peak area	Plasma	Saline
Reversed phase NEGATIVE ION MODE	nicotinamide	0.8229	Peak area	Plasma	Angiotensin II
Reversed phase NEGATIVE ION MODE	nicotinamide	0.8257	Peak area	Plasma	Saline
Reversed phase NEGATIVE ION MODE	nicotinamide	0.8572	Peak area	Plasma	Saline
Reversed phase NEGATIVE ION MODE	nicotinamide	0.865	Peak area	Plasma	Saline
Reversed phase NEGATIVE ION MODE	nicotinamide	0.9062	Peak area	Plasma	Angiotensin II
Reversed phase NEGATIVE ION MODE	nicotinamide	0.9109	Peak area	Plasma	Angiotensin II
Reversed phase NEGATIVE ION MODE	nicotinamide	0.9599	Peak area	Plasma	Saline
Reversed phase NEGATIVE ION MODE	nicotinamide	1.0401	Peak area	Plasma	Saline
Reversed phase NEGATIVE ION MODE	nicotinamide	1.0435	Peak area	Plasma	Angiotensin II
Reversed phase NEGATIVE ION MODE	nicotinamide	1.0532	Peak area	Plasma	Saline
Reversed phase NEGATIVE ION MODE	nicotinamide	1.1105	Peak area	Plasma	Angiotensin II
Reversed phase NEGATIVE ION MODE	nicotinamide	1.2197	Peak area	Plasma	Angiotensin II
Reversed phase NEGATIVE ION MODE	nicotinamide	1.2731	Peak area	Plasma	Saline
Reversed phase NEGATIVE ION MODE	nicotinamide	1.2962	Peak area	Plasma	Angiotensin II
Reversed phase NEGATIVE ION MODE	nicotinamide	1.3781	Peak area	Plasma	Saline
Reversed phase NEGATIVE ION MODE	nicotinamide	1.5369	Peak area	Plasma	Angiotensin II
Reversed phase NEGATIVE ION MODE	nicotinamide	1.6232	Peak area	Plasma	Saline
Reversed phase NEGATIVE ION MODE	nicotinamide	1.6286	Peak area	Plasma	Saline
Reversed phase NEGATIVE ION MODE	nicotinamide	1.8801	Peak area	Plasma	Angiotensin II